HF
VINC

HRT Financial’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

HRT Financial’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,990
Closed -$15K – 3616
2024
Q4 		$15K Buy
2,990
+2,255
+307% +$14.8K ﹤0.01% 2250
2024
Q3 		$10K Buy
+735
New +$10.1K ﹤0.01% 2231
2021
Q1 		– Sell
-1,580
Closed -$660K – 3257
2020
Q4 		$660K Sell
1,580
-24
-1% -$7.56K 0.01% 878
2020
Q3 		$402K Buy
+1,604
New +$326K 0.01% 985

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's VINC Position: Q1 2025 in Review

HRT Financial sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2025, closing a stake of 2,990 shares — an estimated $15K sold.

HRT Financial first reported a position in VINC in Q3 2020 and held it in 4 quarters. The position peaked at $660K in Q4 2020. 14 funds tracked by Wall St. Rank hold VINC as of Q1 2025.

  • HRT Financial reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 2,990 Vincerx Pharma, Inc. Common Stock shares in Q1 2025, an estimated $15K.
  • HRT Financial first reported a position in Vincerx Pharma, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • HRT Financial's Vincerx Pharma, Inc. Common Stock position peaked at $660K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.